US FDA moves to up-schedule hydrocodone combos
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration has decided to pursue making access more restrictive for medicines like Vicodin and Lortab, which combine hydrocodone with acetaminophen/paracetamol – determining their status under the Controlled Substances Act should be switched from Schedule III controlled substance status to Schedule II1.